Mark Rothera, President and CEO at Viracta Therapeutics, Inc. (VIRX), bought 100,000 shares at $0.49 ($49K) on 2023-11-30, disclosed to the SEC on 2023-12-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.49 | 52,094 | $26K | 52.1% |
| 2 | $0.49 | 47,906 | $23K | 47.9% |
| Total | $0.49 avg | 100,000 | $49K | 100% |
| Filing → |
| PTCT | SELL | 2015-03-13 | $23K | — | Filing → |
| PTCT | SELL | 2015-02-25 | $2.4M | — | Filing → |
| PTCT | SELL | 2015-01-22 | $180K | — | Filing → |